TARDBP and amyotrophic lateral sclerosis: Altogether, our results reveal a novel molecular mechanism behind TDP-43-derived pathologies and put forward novel therapeutic strategies aimed to potentiate inhibitory signaling or balancing the levels of neurotransmitters may succeed to control motoneurons hyperexcitability in ALS affected individuals.